金城医药(300233)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300233 金城医药

已收盘 12-26 15:00:00

{"stockData":{"symbol":"300233","market":"SZ","secType":"STK","nameCN":"金城医药","latestPrice":14.29,"timestamp":1766732631000,"preClose":14.29,"halted":0,"volume":6991570,"delay":0,"changeRate":0,"floatShares":372000000,"shares":384000000,"eps":0.2014,"marketStatus":"已收盘","change":0,"latestTime":"12-26 15:00:00","open":14.5,"high":14.6,"low":14.2,"amount":100000000,"amplitude":0.028,"askPrice":14.3,"askSize":267,"bidPrice":14.29,"bidSize":311,"shortable":0,"etf":0,"ttmEps":0.2014,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766971800000},"marketStatusCode":5,"adr":0,"adjPreClose":14.29,"symbolType":"stock","openAndCloseTimeList":[[1766712600000,1766719800000],[1766725200000,1766732400000]],"highLimit":15.72,"lowLimit":12.86,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":383874587,"isCdr":false,"pbRate":1.5,"roa":"--","peRate":70.953327,"roe":"0.85%","epsLYR":0.52,"committee":0.419325,"marketValue":5486000000,"turnoverRate":0.0188,"status":2,"floatMarketCap":5312000000},"requestUrl":"/m/hq/s/300233","defaultTab":"news","newsList":[{"id":"2594298745","title":"金城医药董事会完成董事长补选及高管聘任","url":"https://stock-news.laohu8.com/highlight/detail?id=2594298745","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594298745?lang=zh_cn&edition=full","pubTime":"2025-12-26 18:19","pubTimestamp":1766744386,"startTime":"0","endTime":"0","summary":"中访网数据  山东金城医药集团股份有限公司于2025年12月26日召开第六届董事会第十九次会议，审议通过了多项重要人事任命。会议选举产生了新任董事长，并对董事会专门委员会成员进行了相应补选。同时，董事会决议聘任了新的高级管理人员及董事会秘书。上述所有议案均获得与会董事全票通过，相关人员的任职资格已事先经公司董事会提名委员会审查通过。此次人事变动标志着金城医药公司治理结构的一次重要调整，相关任命将影响公司未来的战略决策与日常运营管理。公司表示，本次会议的召集、召开及表决程序均符合《公司法》及《公司章程》的规定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251226/31895235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300233","BK0239","BK0028"],"gpt_icon":0},{"id":"2593422889","title":"金城医药：截至2025年12月20日股东总户数为27,549户","url":"https://stock-news.laohu8.com/highlight/detail?id=2593422889","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593422889?lang=zh_cn&edition=full","pubTime":"2025-12-24 15:04","pubTimestamp":1766559863,"startTime":"0","endTime":"0","summary":"证券之星消息，金城医药(300233)12月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2025年12月20日股东人数是多少？金城医药回复：投资者，您好，截至2025年12月20日公司股东总户数为27,549户，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400019007.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300233","BK0028","BK0239"],"gpt_icon":0},{"id":"2590659179","title":"金城医药(300233.SZ)实控人赵叶青收到行政处罚决定书","url":"https://stock-news.laohu8.com/highlight/detail?id=2590659179","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590659179?lang=zh_cn&edition=full","pubTime":"2025-12-11 17:51","pubTimestamp":1765446684,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金城医药 公告，公司2025年12月10日收到实际控制人赵叶青先生的通知，其收到中国证监会《行政处罚决定书》。公告显示，2017年8月18日至2020年2月10日，赵叶青、王震、刘峰3人共同操纵“金城医药”股票。中国证监会决定：一、依据2005年《证券法》第二百零三条的规定，对赵叶青、王震、刘峰处以300万元罚款，其中赵叶青承担150万元，王震承担120万元，刘峰承担30万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380455.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"金城医药(300233.SZ)实控人赵叶青收到行政处罚决定书","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0028","300233"],"gpt_icon":0},{"id":"2590598961","title":"金城医药：截至2025年12月10日股东户数为26,997户","url":"https://stock-news.laohu8.com/highlight/detail?id=2590598961","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590598961?lang=zh_cn&edition=full","pubTime":"2025-12-11 15:42","pubTimestamp":1765438929,"startTime":"0","endTime":"0","summary":"证券之星消息，金城医药(300233)12月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2025年12月10日公司股东人数是多少？金城医药回复：投资者，您好，截至2025年12月10日公司股东总户数为26,997户，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100019727.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300233","BK0028","BK0239"],"gpt_icon":0},{"id":"2588702993","title":"金城医药：截至2025年11月30日股东户数为27,320户","url":"https://stock-news.laohu8.com/highlight/detail?id=2588702993","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588702993?lang=zh_cn&edition=full","pubTime":"2025-12-02 08:57","pubTimestamp":1764637035,"startTime":"0","endTime":"0","summary":"证券之星消息，金城医药(300233)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至11月30日公司的股东人数是多少？谢谢金城医药回复：投资者，您好，截至2025年11月30日公司股东总户数为27,320户，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200004453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","300233"],"gpt_icon":0},{"id":"2586316225","title":"金城医药（300233）披露终止意向性合作事项，11月27日股价下跌0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586316225","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586316225?lang=zh_cn&edition=full","pubTime":"2025-11-27 22:14","pubTimestamp":1764252866,"startTime":"0","endTime":"0","summary":"截至2025年11月27日收盘，金城医药报收于16.98元，较前一交易日下跌0.06%，最新总市值为65.18亿元。该股当日开盘17.18元，最高17.2元，最低16.84元，成交额达9209.09万元，换手率为1.46%。后续双方多次延长排他性谈判期限，但因谈判进展不及预期，关键条款未达成一致，公司决定终止该意向性合作。该框架协议为意向性约定，未签署正式协议，终止不会对公司财务状况和生产经营产生影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700038399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300233","BK0239"],"gpt_icon":0},{"id":"2586466942","title":"金城医药最新公告：终止与GiskitPharmaB.V.的意向性合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2586466942","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586466942?lang=zh_cn&edition=full","pubTime":"2025-11-27 17:43","pubTimestamp":1764236585,"startTime":"0","endTime":"0","summary":"金城医药(300233.SZ)公告称，公司与荷兰GiskitPharmaB.V.就ExEmFoam在中国境内独家排他的商业化权益进行谈判，但合作事项的谈判进展不及预期，且各方未就关键问题达成一致意见。公司决定终止上述意向性合作项目，该终止不会对公司财务状况和生产经营产生影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700025932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300233","BK0239"],"gpt_icon":0},{"id":"2586234168","title":"金城医药：截至2025年11月20日股东总户数为26,884户","url":"https://stock-news.laohu8.com/highlight/detail?id=2586234168","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586234168?lang=zh_cn&edition=full","pubTime":"2025-11-26 16:25","pubTimestamp":1764145518,"startTime":"0","endTime":"0","summary":"证券之星消息，金城医药(300233)11月26日在投资者关系平台上答复投资者关心的问题。投资者提问：请问11月20日的股东人数多少，谢谢金城医药回复：投资者，您好，截至2025年11月20日公司股东总户数为26,884户，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600021083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300233","BK0028","BK0239"],"gpt_icon":0},{"id":"2584626987","title":"金城医药最新公告：子公司金城生物收到谷胱甘肽原料药CEP证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2584626987","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584626987?lang=zh_cn&edition=full","pubTime":"2025-11-18 16:50","pubTimestamp":1763455856,"startTime":"0","endTime":"0","summary":"金城医药(300233.SZ)公告称，公司全资子公司金城生物收到欧洲药品质量管理局签发的谷胱甘肽原料药欧洲药典适用性证书，证书生效日期为2025年11月17日。该证书表明该原料药已符合欧洲药典标准，可在欧洲市场进行销售，有助于金城生物进一步扩展海外市场，提升公司在原料药市场的竞争力。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800020737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300233","BK0028","BK0239"],"gpt_icon":0},{"id":"2584798586","title":"股市必读：金城医药(300233)股东户数2.67万户，较上期增加0.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584798586","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584798586?lang=zh_cn&edition=full","pubTime":"2025-11-18 03:41","pubTimestamp":1763408471,"startTime":"0","endTime":"0","summary":"截至2025年11月17日收盘，金城医药报收于17.6元，下跌1.4%，换手率2.32%，成交量8.61万手，成交额1.53亿元。当日关注点来自交易信息汇总：11月17日主力资金净流出192.67万元，游资资金净流入704.23万元。股本股东变化股东户数变动截至2025年11月10日，金城医药股东户数为2.67万户，较10月31日增加122.0户，增幅0.46%。户均持股数量由上期的1.44万股减少至1.44万股，户均持股市值为25.01万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800003391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","300233"],"gpt_icon":0},{"id":"2583580991","title":"金城医药：截至2025年11月10日股东总户数为26,735户","url":"https://stock-news.laohu8.com/highlight/detail?id=2583580991","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583580991?lang=zh_cn&edition=full","pubTime":"2025-11-13 08:54","pubTimestamp":1762995248,"startTime":"0","endTime":"0","summary":"证券之星消息，金城医药(300233)11月12日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，截止到2025年11月10日股东人数是多少？金城医药回复：投资者，您好，截至2025年11月10日公司股东总户数为26,735户，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300008141.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300233","BK0028","BK0239"],"gpt_icon":0},{"id":"2581263207","title":"金城医药(300233.SZ)子公司拟向海默尼出售一项药品生产技术及上市许可持有人权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2581263207","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581263207?lang=zh_cn&edition=full","pubTime":"2025-11-05 19:31","pubTimestamp":1762342301,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金城医药(300233.SZ)公告，公司全资子公司北京金城泰尔制药有限公司(简称“金城泰尔”)拟向海默尼(上海)医药科技有限公司(简称“海默尼”)转让所持有的“普罗雌烯阴道用软胶囊生产技术及上市许可持有人权益”。金城泰尔合法持有“普罗雌烯阴道用软胶囊(商品名：朗依更宝芬®)”的药品批准文号。经交易双方协商一致，标的产品转让的总费用(含税)为5000万元。本次权益转让符合金城泰尔整体的产品发展战略，有利于优化金城泰尔产品结构，提高资产运营效率，进一步优化资产结构。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1365687.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0028","300233"],"gpt_icon":0},{"id":"2581253397","title":"金城医药最新公告：独立董事李福利因公务原因连续两次未亲自出席董事会会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2581253397","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581253397?lang=zh_cn&edition=full","pubTime":"2025-11-05 19:09","pubTimestamp":1762340967,"startTime":"0","endTime":"0","summary":"金城医药(300233.SZ)公告称，公司独立董事李福利因公务原因，连续两次未能亲自出席第六届董事会第十七次会议和第六届董事会第十八次会议。李福利已委托其他董事代为表决相关议案，并对董事会会议作出的决议无异议。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500034903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","300233"],"gpt_icon":0},{"id":"2580273686","title":"金城医药：截至2025年10月31日股东户数26,613户","url":"https://stock-news.laohu8.com/highlight/detail?id=2580273686","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580273686?lang=zh_cn&edition=full","pubTime":"2025-11-04 09:03","pubTimestamp":1762218194,"startTime":"0","endTime":"0","summary":"证券之星消息，金城医药(300233)11月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2025年10月31日，公司股东人数有多少？金城医药回复：投资者，您好，截至2025年10月31日公司股东总户数26,613户，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400006645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","300233"],"gpt_icon":0},{"id":"2578674948","title":"金城医药（300233）2025年三季报简析：净利润同比下降79.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578674948","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578674948?lang=zh_cn&edition=full","pubTime":"2025-10-28 06:08","pubTimestamp":1761602929,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期金城医药发布2025年三季报。根据财报显示，金城医药净利润同比下降79.1%。截至本报告期末，公司营业总收入19.32亿元，同比下降23.19%，归母净利润3157.71万元，同比下降79.1%。按单季度数据看，第三季度营业总收入5.72亿元，同比下降24.44%，第三季度归母净利润-1180.61万元，同比下降157.7%。去年的净利率为6.16%，算上全部成本后，公司产品或服务的附加值一般。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800006588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300233"],"gpt_icon":0},{"id":"2578163938","title":"金城医药(300233)10月20日股东户数2.58万户，较上期增加0.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578163938","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578163938?lang=zh_cn&edition=full","pubTime":"2025-10-26 17:17","pubTimestamp":1761470239,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金城医药披露，截至2025年10月20日公司股东户数为2.58万户，较10月10日增加128.0户，增幅为0.5%。在化学制药行业个股中，金城医药股东户数低于行业平均水平，截至10月20日，化学制药行业平均股东户数为3.26万户。从股价来看，2025年10月10日至2025年10月20日，金城医药区间跌幅为11.2%，在此期间股东户数增加128.0户，增幅为0.5%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600009731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300233","BK0239","BK0028"],"gpt_icon":0},{"id":"2576083463","title":"金城医药(300233.SZ)：吗啉硝唑氯化钠注射液取得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2576083463","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576083463?lang=zh_cn&edition=full","pubTime":"2025-10-20 17:01","pubTimestamp":1760950917,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金城医药 公告，公司控股子公司广东金城金素制药有限公司的通知，金城金素收到国家药品监督管理局下发的吗啉硝唑氯化钠注射液药品注册证书。公告显示，吗啉硝唑为5-硝基咪唑类抗菌药物，本品通过将奥硝唑中不稳定的氯离子改为较为稳定的吗啉环，使其结构更稳定，且不良反应发生率更低。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357088.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"金城医药(300233.SZ)：吗啉硝唑氯化钠注射液取得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","300233","BK0239"],"gpt_icon":0},{"id":"2576082629","title":"金城医药子公司普罗雌烯乳膏补充申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2576082629","media":"中金财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576082629?lang=zh_cn&edition=full","pubTime":"2025-10-17 16:34","pubTimestamp":1760690086,"startTime":"0","endTime":"0","summary":"中访网数据 山东金城医药集团股份有限公司近日宣布，其全资子公司北京金城泰尔制药有限公司收到国家药品监督管理局下发的《药品补充申请批准通知书》，涉及产品普罗雌烯乳膏。此次批准事项包括变更辅料种类及用量、生产工艺以及质量标准。根据相关要求，相关变更需自获批之日起6个月内实施。　　金城医药表示，此次补充申请获得批准有助于提升普罗雌烯乳膏的产品竞争力，但不会对公司当期业绩产生重大影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251017/31715480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300233","BK0239","BK0028"],"gpt_icon":0},{"id":"2575261698","title":"金城医药：尼古丁盐复合物可用于制备口含烟","url":"https://stock-news.laohu8.com/highlight/detail?id=2575261698","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575261698?lang=zh_cn&edition=full","pubTime":"2025-10-14 15:48","pubTimestamp":1760428090,"startTime":"0","endTime":"0","summary":"证券之星消息，金城医药(300233)10月14日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！请问公司尼古丁盐复合物的产能是多少？尼古丁盐复合物主要用途是什么？是否会大幅增加尼古丁的附加值？谢谢！金城医药回复：投资者，您好，尼古丁盐复合物可用于制备口含烟。 感谢您关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101400048514.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300233","BK0239","BK0028"],"gpt_icon":0},{"id":"2575261384","title":"金城医药：截至2025年10月10日股东户数为25,719户","url":"https://stock-news.laohu8.com/highlight/detail?id=2575261384","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575261384?lang=zh_cn&edition=full","pubTime":"2025-10-14 15:42","pubTimestamp":1760427727,"startTime":"0","endTime":"0","summary":"证券之星消息，金城医药(300233)10月14日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问现在的股东户数是多少？金城医药回复：投资者，您好，截至2025年10月10日，公司股东总户数为25,719户，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101400047446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300233","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766779669749,"stockEarnings":[{"period":"1week","weight":-0.0152},{"period":"1month","weight":-0.1589},{"period":"3month","weight":-0.2443},{"period":"6month","weight":-0.1562},{"period":"1year","weight":0.1834},{"period":"ytd","weight":0.221}],"compareEarnings":[{"period":"1week","weight":0.0188},{"period":"1month","weight":0.0257},{"period":"3month","weight":0.0354},{"period":"6month","weight":0.1575},{"period":"1year","weight":0.1664},{"period":"ytd","weight":0.1826}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东金城医药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"27549人(较上一季度增加2.04%)","perCapita":"13492股","listingDate":"2011-06-22","address":"山东省淄博市淄川区经济开发区双山路1号","registeredCapital":"38387万元","survey":"　　山东金城医药集团股份有限公司的主营业务是医药中间体、原料药、口服及外用制剂以及注射剂的研发、生产和销售。公司的主要产品是头孢侧链活性酯系列产品、生物制药及特色原料药、制剂以及其他医药化工产品。","listedPrice":18.6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金城医药(300233)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金城医药(300233)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金城医药,300233,金城医药股票,金城医药股票老虎,金城医药股票老虎国际,金城医药行情,金城医药股票行情,金城医药股价,金城医药股市,金城医药股票价格,金城医药股票交易,金城医药股票购买,金城医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金城医药(300233)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金城医药(300233)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}